Welcome to
On Feet Nation
Coin Master free Spins Links Online
Thomas Shaw Online
Smith Online
Cricket Machinery LLC Online
asimseo Online
Tim Online
Posted by Coin Master free Spins Links on April 26, 2024 at 4:52am 0 Comments 0 Likes
Posted by Coin Master free Spins Links on April 26, 2024 at 4:51am 0 Comments 0 Likes
Posted by Coin Master free Spins Links on April 26, 2024 at 4:50am 0 Comments 0 Likes
The global Nerve Repair And Regeneration Market size is expected to reach USD 20.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.16% from 2023 to 2030. Demand for neurological disorder therapies owing to the increasing incidence and rising awareness regarding the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are projected to boost market growth.
In January 2016, the EU Horizon 2020 program funded a research project ‘Autostem’, launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects for new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market. In July 2018, Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).
In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and the usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.
Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM's portfolio is complementary to Stryker's Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, the Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.
Related Press Release@ Nerve Repair And Regeneration Market Report
List of Key Players of Nerve Repair And Regeneration Market
Nerve Repair And Regeneration Market Report Highlights
Related Reports@
Nerve Monitoring Devices Market
Peripheral Nerve Injuries Market
Nerve Repair And Regeneration Market Segmentation
Grand View Research has segmented the global nerve repair and regeneration market on the basis of product, surgery, and region:
Nerve Repair and Regeneration Product Outlook (Revenue, USD Million, 2018 - 2030)
Nerve Repair and Regeneration Surgery Outlook (Revenue, USD Million, 2018 - 2030)
Nerve Repair and Regeneration Regional Outlook (Revenue, USD Million, 2018 - 2030)
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation